Advertisement
Screener

ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ARCTURUS THERAPEUTICS HOLDINGS INC. Cash Flow Breakdown

Cash flow breakdown shows where ARCTURUS THERAPEUTICS HOLDINGS INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $74.27M went out.
  • Fiscal year ended 2025-12-31: from investing, $230.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $13.38M came in.
  • Fiscal year ended 2025-12-31: change in cash, $61.12M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$74.27M-$230.00K-$15.00M$15.00M$11.69M$1.69M*-$61.12M
2024-12-31-$59.75M-$648.00K$4.74M$682.00K*-$54.98M
2023-12-31-$18.10M-$2.90M-$47.36M$20.00M$2.67M$609.00K*-$45.09M
2022-12-31$31.99M-$7.73M-$5.00M$1.73M$21.41M
2021-12-31-$135.04M-$3.41M$46.60M$902.00K$515.00K*-$90.43M
2020-12-31-$42.86M-$1.74M$423.82M$12.33M*$391.54M
2019-12-31-$6.45M-$818.00K$4.95M$21.28M$15.68M*$34.64M
2018-12-31-$20.76M$22.13M$9.87M$332.00K$11.58M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$19.91M*$18.00K*$0.00*$0.00*
2026-03-31-$19.44M$34.00K$0.00$16.00K-$19.39M
2025-12-31-$16.23M*$88.00K*$0.00*$0.00*$0.00*$11.69M*
2025-09-30-$17.15M*-$181.00K*$0.00*$0.00*$640.00K*$585.00K*
2025-06-30-$5.75M*$0.00*$0.00*$274.00K*-$15.00M*
2025-03-31-$35.14M-$137.00K$15.00M$195.00K-$20.08M
2024-12-31-$284.00K*$0.00*$134.00K*
2024-09-30-$23.76M*-$80.00K*$11.00K*$682.00K*
2024-06-30-$30.14M*-$328.00K*$2.40M*
2024-03-31-$5.56M-$240.00K$2.19M-$3.61M
2023-12-31-$629.00K*-$875.00K*-$20.00M*$0.00*$1.34M*
2023-09-30-$32.41M*-$981.00K*$0.00*$1.23M*$20.61M*
2023-06-30$50.81M*-$354.00K*$0.00*
2023-03-31-$35.87M-$691.00K-$27.36M-$63.93M
2022-12-31$160.26M*-$3.81M*-$3.00M*$768.00K*
2022-09-30-$42.41M*-$2.19M*$369.00K*-$1.59M*
2022-06-30-$36.82M*$378.00K*$257.00K*
2022-03-31-$49.04M-$2.11M$336.00K-$50.81M
2021-12-31-$42.50M*-$1.12M*$0.00*$230.00K*
2021-09-30-$16.65M*-$1.77M*$0.00*$177.00K*$515.00K*
2021-06-30-$32.94M*-$404.00K*$0.00*$82.00K*
2021-03-31-$42.95M-$118.00K$46.60M$413.00K$3.94M
2020-12-31-$6.63M*-$697.00K*$161.94M*$1.26M*
2020-09-30-$15.88M*-$434.00K*$186.58M*$645.00K*
2020-06-30-$8.49M*-$469.00K*$698.00K*$84.91M*
2020-03-31-$11.86M-$142.00K$118.00K-$11.88M
2019-12-31-$7.54M*-$315.00K*$0.00*$5.03M*
2019-09-30-$2.84M*-$159.00K*$5.73M*$15.59M*
2019-06-30$9.34M*-$266.00K*
2019-03-31-$5.41M-$78.00K-$5.49M
2018-12-31-$5.76M*$2.27M*$0.00*$9.87M*
2018-09-30-$6.79M*$7.82M*-$19.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Rezolute, Inc. (RZLT)United States$0.382B-6.45
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63